Skip to content
USAID: From The American People TB-DIAH: Tuberculosis Data, Impact Assessment and Communications Hub
  • Knowledge Hub
  • Data Hub
  • Home
  • About
    • Project Overview & Objectives
    • TB DIAH Team
  • Countries
    • Afghanistan
    • Bangladesh
    • Burma
    • Cambodia
    • DRC
    • Ethiopia
    • India
    • Indonesia
    • Kenya
    • Kyrgyz Republic
    • Malawi
    • Mozambique
    • Nigeria
    • Pakistan
    • Philippines
    • South Africa
    • Tajikistan
    • Tanzania
    • Uganda
    • Ukraine
    • Uzbekistan
    • Vietnam
    • Zambia
    • Zimbabwe
  • Tools
    • ARCAssessment of Data Collection, Reporting & Analysis Capacity
    • D2ACData-to-Action Continuum Toolkit
    • MESSAM&E and Surveillance Systems Assessment
    • PBMEFPerformance-Based M&E Framework
    • QTSAQuality of Tuberculosis Services Assessment
    • STEPSurveillance and TB M&E Strengthening Plan
  • Resources
    • Capacity Strengthening
    • Center of Excellence
    • e-Learning Courses
    • NTP Website Activity
    • Resource Library
  • News
    • TB DIAH Digest
    • Social Media
    • 2023 Union Conference
    • Webinars
What we're reading and watching
COVID-19 and Tuberculosis: What We’re Reading and Watching

What we're reading and watching

The COVID-19 pandemic continues to present challenges for programs working to prevent and treat TB. In the third installment of this series, we offer recent resources that shed light on the implications of COVID-19 on TB prevention, diagnosis, and treatment.

Sessions from the Union World Conference on Lung Health
International Union Against Tuberculosis and Lung Disease (October 2020)
COVID-19 was an important topic at the 51st Union World Conference on Lung Health, which recently took place online. This collection of presentations related to COVID-19 is available to the public, and more session recordings are available for conference attendees and Union members.

Building a tuberculosis-free world while responding to the COVID-19 pandemic
The Lancet (October 24, 2020)
This journal article reflects on the how COVID-19 is affecting efforts to work towards an end to TB and discusses the emerging opportunity to leverage the pandemic response to address TB.

Tuberculosis (TB) during the COVID-19 pandemic: Why we can’t afford to forget the world’s largest infectious disease killer
London School of Hygiene and Tropical Medicine (October 21, 2020)
This webinar provided insights into the impacts of the current pandemic on tuberculosis, exploring how access to TB services, TB diagnosis, vaccine development, and multidrug-resistant TB are being affected.

Live with Dr. Anthony S. Fauci: COVID-19 and its Global Impact on AIDS, TB, and Malaria
Friends of the Global Fight Against AIDS, Tuberculosis and Malaria (September 11, 2020)
This video shares a conversation with Dr. Anthony S. Fauci exploring how the coronavirus pandemic is impacting low- and middle-income countries around the world, the threat it poses to long-term U.S. global health investments, and how the U.S. can help.

Maintaining essential child and adolescent TB services during the COVID-19 pandemic: practical solutions and lessons learnt
The International Union Against Tuberculosis and Lung Disease (September 3, 2020)
This webinar provided practical experiences and perspectives from healthcare workers and program managers on how they work with relevant stakeholders to maintain the most important child and adolescent TB prevention, case finding, and treatment services while protecting families and staff in different settings around the world.

It’s Time to Use Covid-19 Innovations and Systems to Reimagine TB Care
Madhukar Pai, Forbes (October 22, 2020)
In this piece, Pai discusses opportunities for the TB field to benefit from innovations stemming from efforts to combat COVID-19 and vice versa.

TB Research Investments Provide Returns in Combating Both TB and COVID-19
Treatment Action Group (August 2020)
This brief, available in English and Portuguese, explores the impact of COVID-19 on TB research and development (R&D) and how tools, concepts, capacity, and infrastructure established through years of public and donor investments in TB R&D have informed and jump-started COVID-19 research and responses.


Filed under: covid-19, TB, tuberculosis
  • Knowledge Hub
  • Data Hub
TB DIAH Project
University of North Carolina
123 West Franklin Street, Suite 330
Chapel Hill, North Carolina 27516 USA
About
Countries
Topics
Resource Library
News
TB DIAH Digest
Special Features
Assessments
TB Data Hub
Objectives

The TB DIAH project is part of USAID's performance-based measures to end TB—the Global Accelerator to End Tuberculosis. This TB DIAH website features a data hub, guidance, and tools to support the work of the global TB community. TB DIAH makes possible optimal analysis and use of TB data to inform national TB programs, policies, and USAID-supported interventions.

This information was produced with the support of the United States Agency for International Development (USAID) under the terms of the TB Data, Impact Assessment and Communications Hub (TB DIAH) Associate Award No. 7200AA18LA00007. TB DIAH is implemented by the University of North Carolina at Chapel Hill, in partnership with John Snow, Inc. Views expressed are not necessarily those of USAID or the United States government.